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Abstract
Background: When used during extracorporeal membrane oxygenation (ECMO), jugular venous bulb catheters,
known as cephalad cannulae, increase venous drainage, augment circuit flow and decompress cerebral venous
pressure. Optimized cerebral oxygen delivery during ECMO may contribute to a reduction in neurological
morbidity. This study describes the use of cephalad cannulae and identifies rudimentary data for jugular venous
oxygen saturation (JVO2) and arterial to jugular venous oxygen saturation difference (AVDO2) in this patient
population.
Results: Patients on venoarterial (VA) ECMO displayed higher JVO2 (P < 0.01) and lower AVDO2 (P = 0.01) than
patients on venovenous (VV) ECMO (P < 0.01). During VV ECMO, JVO2 was higher and AVDO2 lower when systemic
pH was < 7.35 rather than > 7.4 (P = 0.01). During VA ECMO, similar differences in AVDO2 but not in JVO2 were
observed at different pH levels (P = 0.01).
Conclusions: Jugular venous saturation and AVDO2 were influenced by systemic pH, ECMO type and patient age.
These data provide the foundation for normative values of JVO2 and AVDO2 in neonates and children treated with
ECMO.
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Introduction
Extracorporeal membrane oxygenation (ECMO) is used
to treat newborn infants and children experiencing life-
threatening cardiorespiratory failure unresponsive to
conventional medical therapy [1,2]. Infants meeting the
required criteria are estimated to have 80% mortality if
they do not receive ECMO compared to approximately
80% survival for those who do receive the treatment [3].
This survival is not without significant cost and morbid-
ity [2]. Substantial investigative interest has focused on
the neurological outcome of patients treated with
ECMO. Optimized cerebral oxygen delivery during
ECMO may limit neurological morbidity associated with
hypoxia.
Monitoring jugular venous oxygen saturation (JVO2)
as a method of approximating global cerebral oxygena-
tion via a jugular venous bulb drainage catheter is a safe
and reliable method in both adults and children [4,5],
including neonates [6,7]. Jugular venous oximetry is
used in the management of patients with increased
intracranial pressure [8-11], as well as intra-operatively
during cardiopulmonary bypass [12] and during neuro-
surgical procedures [13]. Jugular venous sampling
enables calculation of arterial to jugular venous oxygen
saturation difference (AVDO2) for more precise moni-
toring of cerebral oxygen content and to aid in the
assurance of adequate oxygen delivery [14,15].
When used during ECMO, jugular venous bulb cathe-
ters, also known as cephalad cannulae, increase venous
drainage, augment circuit flow, and decompress cerebral
venous circulation. Currently there are insufficient data
available to clarify the results of samples obtained from
cephalad cannulae used as monitoring tools during
ECMO. The purpose of this study was to describe the
use of cephalad cannulae and the data obtained from
jugular venous blood samples as an additional tool in
the management of the ECMO patient. Our goal was to
1Critical Care Medicine
Full list of author information is available at the end of the article
Pettignano et al. Critical Care 1997, 1:95
http://ccforum.com/
© 1997 Current Science Ltd
identify rudimentary data that would be foundation for




In this retrospective study, we reviewed the medical
records of all the patients treated with ECMO in whom
a cephalad cannula was placed. Data collected included
vital signs, arterial blood gases, jugular venous blood
gases, ECMO flow rate, as well as the type of ECMO
used. These data were recorded every 8 h at the time of
jugular venous blood sampling as per our ECMO proto-
col. Patient data were compared using the following
categories: neonatal, pediatric, and the type of ECMO
utilized [venoarterial (VA) or venovenous (VV)].
ECMO procedure
Cephalad cannulae are inserted via an arterial catheter
into the jugular vein. The size of the catheter is based
on patient weight and blood vessel diameter. In neo-
nates this is most commonly a catheter between 10 and
14 F. In pediatric patients, the same size or one size
smaller than the venous drainage catheter is used. The
catheter is then advanced in a retrograde fashion into
the jugular vein until resistance is met. Optimal cannula
flow is considered to be between one-third and one-half
of total ECMO flow. The insertion of the cephalad
catheter is performed at the time of ECMO cannulation.
All neonates unergoing ECMO received sedation with
morphine and lorazepam without neuromuscular block-
ade. Pediatric patients routinely received sedation with
an opioid (fentanyl or morphine) and a benzodiazepine
(midazolam or lorazepam). Neuromuscular blockade
was achieved in the pediatric patients with either vecur-
onium or atracurium.
Measurements
Arteriovenous oxygen content differece was calculated
using the formula:
AVDO2 = arterial oxygen content (CaO2) - venous
oxygen content (CVO2)
where CaO2 (vol%) = [hemoglobin × arterial satura-
tion (%) × 1.36] + [arterial PO2 × 0.0031] and CVO2
(vol%) = [hemoglobin × venous saturation (%) × 1.36 ]
+ [venous PO2 × 0.0031].
Systemic venous saturation (SVO2) was not measured
since recirculation and return of ECMO derived oxyge-
nated blood into the venous circulaton with VV ECMO
would render this measurement inaccurate.
Data analysis
All data are presented as mean ± standard deviation.
Data analyses of changes in JVO2 or AVDO2 over time
were performed using analysis of variance (ANOVA) for
repeated measures. Analyses of data between groups
and under different clinical conditions were performed
utilizing ANOVA with post hoc analysis using Fisher’s
test of least squares. Linear and non-linear correlation
analysis was used to determine any correlation between
physiologic parameters, ECMO flow, and JVO2 or




Forty-seven patients were studied including 36 neonates
and 11 pediatric patients. The demographic characteris-
tics of the patient population are described in Table 1.
Three patients were removed from the study due to
malfunction of the cephalad cannulae or incomplete
data collection. Three hundred and eight measurements
were reviewed. Neonatal ECMO patients carried a mor-
tality of 11%, while the mortality of pediatric ECMO
patients was 18%. Both pediatric deaths occurred in
patients with underlying cardiac anomalies. The diag-
noses of all patients are shown in Table 2.
Monitoring
Demographic data collected included name, age, diag-
nosis and weight. Blood gas results were collected
every 8 h for the first 3 days of the ECMO run, and
included patient arterial (postductal in neonates),
cephalad venous, pre-membrane venous and post-
membrane measurements. Vital signs and ECMO flow
were also collected to coincide with the time of blood
gas analysis.
There was no correlation between JVO2 and mean
arterial blood pressure, heart rate, PaO2, PaCO2, periph-
eral saturation or ECMO flow. Similarly, there was no
correlation between these parameters and AVDO2. The
above mentioned clinical parameters were maintained
within a normal range during the ECMO run. The num-
ber of values obtained at extremes was small.
Table 1 Demographic data
Neonatal Pediatric
Total in Group
VV with ceph 31 7
VA with ceph 5 4
Total 36 11
Weight 2.5-4.7 kg 2.7-61 kg




VV = venovenous, VA = venoarterial, ceph = cephalad drain.
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Mean JVO2 and AVDO2 changed over the course of
the ECMO run in patients treated with VV ECMO, but
not in patients treated with VA ECMO. Patients on VA
ECMO had higher JVO2 (P < 0.01) and lower AVDO2
(P = 0.01) than patients on VV ECMO. Neonates had
lower JVO2 and higher AVDO2 than pediatric patients.
When the type of ECMO was considered, neonates on
VA ECMO had lower JVO2 and higher AVDO2 than
pediatric patients on VA ECMO. Neonates on VV
ECMO had higher AVDO2 than pediatric patients, but
JVO2 was similar. Multivariate analysis showed that the
type of ECMO was more important than the patient’s
age group in determining both AVDO2 and JVO2.
During VV ECMO, JVO2 was higher and AVDO2 was
lower when the systemic pH was < 7.35 than when the
pH was >7.4. During VA ECMO, similar difference in
AVDO2, but not in JVO2, were observed at different pH
levels (P = 0.01).
There were no complications (ie increased bleeding,
venous thrombosis, infection or limitation of ECMO
flow) due to the cephalad cannulae. Clotting of the
cephalad cannula necessitated its removal in four out of
47 cases (8.5%). Clots were identified by visual inspec-
tion and/or blood flow decreasing to less than 50 cm3/
min as measured by a transit time flowmeter (Transonic
Systems Inc, Ithica, NY, USA). Clotted catheters were
identified and removed at 5, 10, 120 and 254 h of
ECMO. The remaining catheters were removed at the
end of ECMO therapy. All catheters were removed with-
out incident. No morbidity was suffered by any patient
who had their cephalad cannula removed due to clot
identification or decreased flow. There were no reported
incidents of intracranial hemorrhage in any of the
patients with cephalad catheters. Long-term neurologic
follow-up was unavailable due to the retrospective nat-
ure of our patients who are referrals from other
institutions, specifically sent for ECMO, then returned
to the referral area once support is terminated.
Discussion
Patients requiring ECMO have experienced varying
degrees of hypoxia, hypotension, and acidosis [1]. Clini-
cal and laboratory data suggest that severe hypoxia,
similar to that occurring in patients requiring ECMO,
alters cerebral autoregulation [16-18]. These studies
demonstrate significant cerebral hyperemia, character-
ized by increased volume and velocity of cerebral blood
flow after severe hypoxia [19]. The initiation of ECMO
also alters cerebral autoregulation in healthy animals
[20,21]. In neonates, initiation of VA ECMO causes an
increase in cerebral blood flow [22,23]. A better under-
standing of cerebral oxygen consumption and delivery
during ECMO may improve the quality of care that we
provide for these patients. Neurological morbidity asso-
ciated with hypoxia and reperfusion injury may therein
be reduced.
Our study demonstrates that, within the normal
ranges of mean arterial blood pressure, arterial oxygen
and carbon dioxide content, JVO2 and AVDO2 were
consistent over time. In addition, changes in ECMO
pump flow were not correlated with changes in JVO2 or
AVDO2. Although it has been suggested that cerebral
blood flow is altered during ECMO [20-23], our data
imply that cerebral autoregulation may remain intact. In
the future, directly monitoring cerebral blood flow may
provide the data needed to address this question. Several
factors were found to be associated with lower JVO2 and
higher AVDO2. During VV ECMO, there was an initial
drop in JVO2 with a corresponding rise in AVDO2, fol-
lowed by stabilization of both. The changes were most
marked during the first 24 h of ECMO, with stabiliza-
tion occurring after 32 h. SVO2 was not measurable
and/or inaccurate because of the delivery of oxygenated
blood directly into the venous circulation and due to
the effects of recirculation on the measurement of
SVO2.
In contrast, there were no changes over time in JVO2
or AVDO2 in patients treated with VA ECMO. How-
ever, the number of patients in this group is small and
it is possible that with a larger population a difference
would be seen. Throughout their course, patients on VA
ECMO had higher JVO2 and lower AVDO2 than
patients on VV ECMO. Similarly, pediatric patients had
higher JVO2 and lower AVDO2 than neonates.
The precise cause of the time-related changes during
VV ECMO are unclear. The differences in JVO2 and
AVDO2 between VV and VA ECMO are most likely
due to varying oxygen delivery to the brain. During VA
ECMO, oxygenated blood from the ECMO circuit is
delivered into the ascending aorta immediately adjacent
Table 2 Diagnoses
VV VA Total
Neonatal Meconium aspiration 12 1 13
Sepsis 4 0 4
Persistent pulmonary hypertension 8 1 9
Congenital diaphragmatic hernia 3 2 5
Lung hypoplasis 2 0 2
Respiratory distress syndrome 2 1 3
Pediatric Acute respiratory distress syndrome 3 0 3
Near drowning 1 0 1
Myocarditis 1 1 2
Asthma 2 0 2
Necrotizing tracheitis 0 1 1
Respiratory syncytial virus 0 1 1
Pneumonitis 0 1 1
W = venovenous; VA = venoarterial.
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to the left common carotid artery. As a result, blood
entering the left common carotid is completely satu-
rated. During VV ECMO, oxygenated blood is returned
to the patient’s venous blood near the right atrium. As
blood from the ECMO circuit reaches the common car-
otid artery it is well mixed with the patient’s venous
blood and is not completely saturated. The potential
contribution of this increased oxygen delivery to cere-
bral reperfusion injury following hypoxia/ischemia in
patients undergoing VA ECMO is unknown.
The cause of the difference identified between neo-
nates and pediatric patients is less clear. Our data sug-
gest that JVO2 and AVDO2 are different in neonates
and pediatric patients. There are two possible reasons
for this finding. The clinical use of neuromuscular
blockade and sedation in our neonatal intensive care
unit (ICU) compared to our pediatric ICUs is different.
Neonates are not routinely paralyzed and receive less
sedation than pediatric patients who are routinely paral-
yzed and heavily sedated. This may be reflected in an
increased oxygen consumption in the neonates giving
them a higher AVDO2 level than the pediatric patients.
secondly, the global oxygen consumption of a neonate
may be higher than that of an older child due to age
alone. The significance and implications of the relatively
higher JVO2 associated with both the VA ECMO and
pediatric ECMO groups is unclear and will require
further study.
Changes in systemic pH were also associated with
changes in JVO2 and AVDO2. We did not find a rela-
tionship between PaCO2 and JVO2 or AVDO2; however,
PaCO2 was clinically maintained in a normal range.
Cain has demonstrated that, in passively hyperventilated
dogs, as pH decreases oxygen consumption also
decreases [24]. This may be the explanation for AVDO2
decreasing with pH in our patients. Alkalosis is a well-
recognized stimulus for cerebral vasoconstriction [25].
Unfortunately, there are on data that define the opti-
mum pH at which oxygen delivery to the brain is ade-
quate. Conversely, excess or ‘luxury’ flow [26] may cause
cerebral reperfusion injury associated with hypoxic
insults. Our data do not allow us to define an optimal
range for pH, but they do suggest that small changes in
pH affect cerebral blood flow in neonatal and pediatric
patients on both VV and VA ECMO.
Summary
In our study population the use of cephalad cannulae
was without complications and was useful in the man-
agement of the ECMO patient. Cephalad cannulae can
provide accurate, consistent readings of JVO2 during the
course of ECMO. Placement of cephalad cannulae at the
initiation of ECMO was without adverse effects. We
identified several factors that may influence oxygen
delivery to the brain during ECMO, including systemic
pH, type of ECMO and age of the patient. Future stu-
dies should attempt to define optimal oxygen delivery to
the brain. This study provides a foundation of normative
values for cephalad monitoring in neonates and pedia-
tric patients on ECMO. Additional investigation is
required to delineate the role cephalad catheters may
play in the clinical monitoring, bedside management
and long-term outcome of patients on ECMO. The use
of cerebral biochemical Markers taken from jugular
venous catheters may help to predict neurodevelopmen-
tal outcome in this patient population [27].
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